Genmab A/S Announces Pipeline and Technology Update

COPENHAGEN, Denmark, April 21, 2010 (GLOBE NEWSWIRE) -- Summary: Genmab has announced a new pre-clinical antibody program, HuMax-cMet, as well as a novel next generation antibody technology.
MORE ON THIS TOPIC